A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis
Melody C. Carter, Irina Marić, Erica Brittain, Yun Bai, Keith Lumbard, Hyejeong Bolan, Daly Cantave, Linda M. Scott, Dean D. Metcalfe
Topics & Concepts
MedicineAnaphylaxisOmalizumabPlaceboTryptaseClinical endpointRandomized controlled trialSystemic mastocytosisPopulationInternal medicineEpinephrineAnesthesiaAllergyMast cellImmunoglobulin EBone marrowImmunologyAntibodyPathologyAlternative medicineEnvironmental healthFood Allergy and Anaphylaxis ResearchMast cells and histamineAllergic Rhinitis and Sensitization